Keyphrases
CD8+ T Cells
100%
Mammalian Target of Rapamycin (mTOR)
100%
Interleukin-33 (IL-33)
100%
Glycolytic Metabolism
100%
Lymphocytic Choriomeningitis Virus Infection
18%
Inflammatory Diseases
9%
CD8+
9%
Mechanistic Studies
9%
T Cell Activation
9%
Innate Immunity
9%
Adaptive Immunity
9%
Therapeutic Strategies
9%
Infectious Diseases
9%
Effector Cells
9%
Cell Activation
9%
Effector T Cells
9%
Control Cell
9%
CD4+ T
9%
Adoptive Transfer
9%
Transfer Test
9%
Glucose Uptake
9%
Elevated Glucose
9%
Glycolytic Enzymes
9%
Glucose Transporter 1 (GLUT1)
9%
Warburg Effect
9%
MTOR Inhibitor
9%
CD8+ T Cell Infiltration
9%
Cytotoxic T Cells
9%
T Cell Regulation
9%
Interleukin-1 Family
9%
Family Play
9%
Lactate Production
9%
Glycolytic Capacity
9%
Anti-CD3/CD28
9%
S6 Ribosomal Protein
9%
Glycolytic Rate
9%
P-S6
9%
Aerobic Glucose Metabolism
9%
Immunology and Microbiology
Interleukin 33
100%
Cytotoxic T-Cell
100%
T Cell Activation
18%
Lymphocytic Choriomeningitis Virus
18%
Viral Disease
18%
Adaptive Immune System
9%
Innate Immune System
9%
Effector Cell
9%
Cytotoxic T Cell
9%
T Cell Regulation
9%
CD8
9%
Cell Activation
9%
Glucose Metabolism
9%
CD4
9%
Infectious Disease
9%
CD28
9%
Interleukin 1 Family
9%
Glucose Transport
9%
Glucose Transporter
9%
CD3 Antigen
9%